ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp. (Nasdaq: ARYA) is a blank-check company that completed its initial public offering in 2018, targeting the life sciences and biopharmaceutical sector. The SPAC was sponsored by an affiliate of Perceptive Advisors, a New York-based healthcare-focused investment firm. ARYA filed an S-1/A amendment with the SEC on September 25, 2018, as part of its IPO registration process. The vehicle was structured to identify and combine with a company in the biotechnology or pharmaceutical space. ARYA Sciences subsequently completed a business combination with Imara Inc., a clinical-stage biopharmaceutical company, in 2020. Sign up at SpacDesk for complete filing history, sponsor profiles, and deal analytics on ARYA Sciences and hundreds of other SPAC transactions.